rHuA1AT (Intrexon)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamerHuA1AT (Intrexon)
Drug Alias NameRecombinant Human Alpha 1-Antitrypsin (Intrexon)ITXN-A1AT
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAlpha-1-antiproteinase stimulants
TargetsAlpha-1-antiproteinase
Therapy Area/IndicationsDiabetes MellitusRespiratory Tract Diseasesalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPrecigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntrexon CorporationPrecigen Inc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusRespiratory Tract Diseasesalpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A
Related LinksN/A